Keyphrases
Mouse Model
100%
Microbiome
100%
Amyotrophic Lateral Sclerosis
100%
Intestine
100%
SOD1G93A Mice
42%
Antimicrobial Peptides
28%
Wild Mice
28%
Motor Neuron
28%
Paneth Cells
28%
Intestinal Microbiome
28%
SOD1G93A
28%
Disease Progression
14%
Escherichia Coli
14%
Effective Treatment
14%
Parkinson's Disease
14%
Microbes
14%
Expression Level
14%
Neurodegenerative Diseases
14%
Gut Microbiome
14%
Intestinal Epithelium
14%
Superoxide Dismutase
14%
Neurological Diseases
14%
Principal Coordinate Analysis (PCoA)
14%
Muscle Atrophy
14%
Intestinal Epithelial Cells
14%
Relative Abundance
14%
Tight Junction
14%
E-cadherin
14%
Enhanced Permeability
14%
Fecal Microbial Community
14%
Host Innate Immune Response
14%
Adherens Junction Proteins
14%
Junction Structure
14%
Tight Junction Proteins
14%
Intestinal Homeostasis
14%
Respiratory Paralysis
14%
Butyrivibrio Fibrisolvens
14%
Neuron Atrophy
14%
α-defensin 5
14%
Immunology and Microbiology
Mouse Model
100%
Intestine
100%
Microbiome
100%
Wild Type Mouse
50%
Paneth Cell
50%
Tight Junction
50%
Antimicrobial Peptides
50%
Innate Immune System
25%
Gut Microbiome
25%
Escherichia coli
25%
Homeostasis
25%
Butyrivibrio fibrisolvens
25%
Cadherin
25%
Adherens Junction
25%
Microorganism
25%
Superoxide Dismutase
25%
Muscle
25%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Amyotrophic Lateral Sclerosis
100%
Microbiome
100%
Wild Type Mouse
28%
Polypeptide Antibiotic Agent
28%
Escherichia coli
14%
Disease Exacerbation
14%
Muscle Atrophy
14%
Neurologic Disease
14%
Uvomorulin
14%
Butyrivibrio fibrisolvens
14%
Protein ZO1
14%
Diaphragm Paralysis
14%
Superoxide Dismutase
14%
Parkinson's Disease
14%
Degenerative Disease
14%
Intestinal Homeostasis
14%
Microorganism
14%